Vanguard Capital Management’s Parabilis Medicines PBLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.3M Buy
1,556,246
+399,284
+35% +$13.9M ﹤0.01% 1891
2026
Q2
$31.7M Buy
+1,156,962
New +$32M ﹤0.01% 2183

Other funds holding PBLS

Vanguard Capital Management's PBLS Position: Q3 2026 in Review

Vanguard Capital Management increased its Parabilis Medicines (PBLS) stake by 35% in Q3 2026, buying an estimated $13.9M and bringing the position to 1,556,246 shares worth $50.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

Vanguard Capital Management first reported a position in PBLS in Q2 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

  • Vanguard Capital Management held 1,556,246 shares of Parabilis Medicines worth $50.3M as of Q3 2026.
  • Vanguard Capital Management bought 399,284 Parabilis Medicines shares in Q3 2026, an estimated $13.9M.
  • Parabilis Medicines made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1891 holding.
  • Vanguard Capital Management first reported a position in Parabilis Medicines in Q2 2026 and has held it in 2 quarters since.
  • 127 funds tracked by Wall St. Rank held Parabilis Medicines as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.